Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (163)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
512
2.470
 Why?
Thrombolytic Therapy
4
2022
110
1.230
 Why?
Fibrinolytic Agents
4
2022
128
1.220
 Why?
Pneumonia, Viral
6
2020
178
1.220
 Why?
Coronavirus Infections
6
2020
188
1.200
 Why?
Tissue Plasminogen Activator
3
2020
109
1.180
 Why?
Pandemics
8
2020
585
0.790
 Why?
Endovascular Procedures
2
2022
178
0.790
 Why?
Cavernous Sinus
1
2022
15
0.750
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
12
0.750
 Why?
Embolization, Therapeutic
1
2022
88
0.700
 Why?
Conflict of Interest
2
2020
26
0.700
 Why?
Iodine Compounds
1
2020
7
0.680
 Why?
Brain Edema
1
2020
36
0.650
 Why?
Brain Ischemia
4
2022
161
0.610
 Why?
Mucopolysaccharidosis II
1
2018
1
0.610
 Why?
Contrast Media
1
2020
193
0.610
 Why?
Cardiology
1
2020
97
0.600
 Why?
Medicare
1
2020
274
0.590
 Why?
Coronary Angiography
1
2020
367
0.590
 Why?
Physicians
1
2020
241
0.540
 Why?
Hospitalization
6
2022
736
0.460
 Why?
Humans
31
2025
52483
0.410
 Why?
Databases, Factual
3
2020
706
0.400
 Why?
Telemedicine
1
2019
494
0.390
 Why?
Aged
12
2025
10121
0.380
 Why?
Headache
2
2022
76
0.350
 Why?
Time Factors
4
2020
2968
0.340
 Why?
Autoimmune Diseases
2
2020
86
0.320
 Why?
Ischemic Attack, Transient
2
2020
57
0.320
 Why?
United States
7
2025
5192
0.310
 Why?
Immunosuppressive Agents
2
2020
243
0.300
 Why?
Female
18
2025
28171
0.300
 Why?
Male
16
2025
26761
0.280
 Why?
Middle Aged
13
2025
13028
0.280
 Why?
Cerebral Hemorrhage
2
2025
97
0.270
 Why?
Arkansas
4
2019
2028
0.250
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
2
0.240
 Why?
Frontotemporal Dementia
1
2025
4
0.240
 Why?
Emergency Service, Hospital
2
2020
522
0.240
 Why?
Secondary Prevention
1
2025
84
0.240
 Why?
Gastrointestinal Hemorrhage
1
2025
89
0.230
 Why?
Tomography, X-Ray Computed
2
2020
1165
0.220
 Why?
Platelet Aggregation Inhibitors
1
2025
181
0.210
 Why?
Triage
2
2021
66
0.210
 Why?
Retrospective Studies
6
2025
6607
0.210
 Why?
Drug Industry
2
2020
40
0.210
 Why?
Thrombectomy
2
2020
72
0.210
 Why?
Neuroimaging
2
2020
94
0.200
 Why?
Atrial Fibrillation
1
2025
200
0.200
 Why?
Anticoagulants
1
2025
270
0.200
 Why?
Critical Care
2
2021
222
0.190
 Why?
Aged, 80 and over
4
2025
3392
0.180
 Why?
Sinus Thrombosis, Intracranial
1
2021
16
0.180
 Why?
Myasthenia Gravis
1
2021
19
0.180
 Why?
Hospitalists
1
2020
11
0.180
 Why?
Intracranial Thrombosis
1
2020
16
0.180
 Why?
Myocardial Infarction
2
2025
412
0.170
 Why?
Ageusia
1
2020
6
0.170
 Why?
Olfaction Disorders
1
2020
7
0.170
 Why?
Neuromuscular Diseases
1
2020
31
0.170
 Why?
Health Services Misuse
1
2020
13
0.170
 Why?
Osmolar Concentration
1
2020
62
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2020
58
0.170
 Why?
Health Care Sector
1
2020
15
0.170
 Why?
Neurologic Examination
1
2020
73
0.170
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.170
 Why?
Mood Disorders
1
2020
59
0.170
 Why?
Multiple Sclerosis
1
2020
72
0.160
 Why?
Time-to-Treatment
1
2020
78
0.160
 Why?
Venous Thrombosis
1
2020
90
0.160
 Why?
Patient Transfer
1
2020
99
0.160
 Why?
Brain Diseases
1
2020
79
0.160
 Why?
Subarachnoid Hemorrhage
1
2020
60
0.160
 Why?
Young Adult
2
2020
4329
0.160
 Why?
Drug-Eluting Stents
1
2020
94
0.160
 Why?
Suicidal Ideation
1
2020
109
0.160
 Why?
Recombinant Fusion Proteins
1
2010
177
0.160
 Why?
Fabry Disease
1
2019
9
0.160
 Why?
Enzyme Replacement Therapy
1
2019
17
0.160
 Why?
Hospitals
1
2020
182
0.160
 Why?
Nervous System Diseases
1
2020
95
0.150
 Why?
Tomography Scanners, X-Ray Computed
1
2018
11
0.150
 Why?
Angiogenesis Inhibitors
1
2010
183
0.150
 Why?
Fluorocarbons
1
2019
61
0.150
 Why?
Angiography, Digital Subtraction
1
2018
27
0.150
 Why?
Neuroprotective Agents
1
2019
101
0.150
 Why?
Seizures
1
2020
208
0.150
 Why?
Pain
1
2020
362
0.140
 Why?
Anxiety
1
2020
300
0.140
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
146
0.140
 Why?
Meningitis
1
2016
24
0.130
 Why?
Referral and Consultation
1
2019
292
0.130
 Why?
Diagnosis, Differential
1
2020
1046
0.130
 Why?
Adult
6
2025
14161
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
307
0.130
 Why?
Antibodies, Monoclonal
1
2010
481
0.130
 Why?
Ovarian Neoplasms
1
2010
459
0.120
 Why?
Plasma Cells
1
2016
239
0.120
 Why?
Magnetic Resonance Imaging
2
2020
1546
0.120
 Why?
RNA-Directed DNA Polymerase
1
2002
5
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
30
0.100
 Why?
DNA, Complementary
1
2002
135
0.100
 Why?
Adolescent
2
2020
6739
0.090
 Why?
Antineoplastic Agents
1
2010
1222
0.090
 Why?
Mycobacterium tuberculosis
1
2002
291
0.090
 Why?
Treatment Outcome
4
2022
5422
0.080
 Why?
Risk Factors
3
2025
3889
0.080
 Why?
Intubation, Intratracheal
2
2021
122
0.080
 Why?
Risk Assessment
2
2025
1327
0.070
 Why?
Cross-Sectional Studies
2
2025
1678
0.070
 Why?
Cohort Studies
2
2022
1542
0.070
 Why?
Prevalence
2
2020
1006
0.070
 Why?
Receptor, Macrophage Colony-Stimulating Factor
1
2025
5
0.060
 Why?
Mexico
1
2025
37
0.060
 Why?
Propensity Score
1
2025
154
0.060
 Why?
Drug Therapy, Combination
1
2025
395
0.060
 Why?
Intracranial Hemorrhages
1
2022
39
0.050
 Why?
Multiple Myeloma
1
2016
3049
0.050
 Why?
Cranial Sinuses
1
2021
8
0.050
 Why?
Industry
1
2020
16
0.040
 Why?
Arthritis, Psoriatic
1
2020
9
0.040
 Why?
Spondylitis, Ankylosing
1
2020
10
0.040
 Why?
Cranial Nerves
1
2020
14
0.040
 Why?
Disease Susceptibility
1
2021
95
0.040
 Why?
Endocrine System Diseases
1
2010
9
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
23
0.040
 Why?
Mortality
1
2020
105
0.040
 Why?
Colitis, Ulcerative
1
2020
67
0.040
 Why?
Arthritis, Rheumatoid
1
2020
116
0.040
 Why?
Maximum Tolerated Dose
1
2019
39
0.040
 Why?
Disease Outbreaks
1
2020
123
0.040
 Why?
Administration, Oral
1
2020
451
0.040
 Why?
Tertiary Care Centers
1
2019
85
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Registries
1
2022
581
0.040
 Why?
Administration, Intravenous
1
2019
73
0.040
 Why?
Mutation
1
2025
1347
0.040
 Why?
Crohn Disease
1
2020
117
0.040
 Why?
Disability Evaluation
1
2019
92
0.040
 Why?
Hemorrhage
1
2020
209
0.040
 Why?
Skin Diseases
1
2010
115
0.040
 Why?
Gastrointestinal Diseases
1
2010
125
0.040
 Why?
Drug Administration Schedule
1
2019
374
0.040
 Why?
Recovery of Function
1
2019
199
0.040
 Why?
Electronic Health Records
1
2021
268
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
236
0.040
 Why?
Comorbidity
1
2019
625
0.040
 Why?
Double-Blind Method
1
2019
713
0.030
 Why?
Patient Readmission
1
2019
246
0.030
 Why?
Prognosis
1
2022
2099
0.030
 Why?
Fatal Outcome
1
2016
197
0.030
 Why?
Follow-Up Studies
1
2020
2279
0.030
 Why?
Prospective Studies
1
2020
2481
0.030
 Why?
Cardiovascular Diseases
1
2010
490
0.030
 Why?
DNA Primers
1
2002
208
0.020
 Why?
Infant
1
2020
3733
0.020
 Why?
Child, Preschool
1
2020
4076
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
405
0.020
 Why?
Transcription, Genetic
1
2002
378
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
187
0.020
 Why?
RNA, Messenger
1
2002
1132
0.020
 Why?
Child
1
2020
7248
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (163) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department